Newsroom
Truveta news releases
Truveta launches Truveta Live Link
A breakthrough prospective research model that unites proprietary data, real-world clinical evidence, expert determination, and integrated storage in one solution BELLEVUE, Wash.—January 13, 2026—Truveta, the health system-led data and analytics company, today...
New Truveta research published in JAMA Network Open reveals declining timeliness in childhood MMR vaccination and identifies early predictors of missed immunizations
BELLEVUE, Wash.—January 2, 2026—Truveta today announced the publication of new peer-reviewed research in JAMA Network Open that provides one of the most comprehensive and timely analyses to date on childhood measles, mumps, and rubella (MMR) vaccination trends in the...
Truveta research published in JAMA Network Open shows rapid uptake of early measles vaccination during Texas outbreak
Truveta’s analysis of early measles, mumps, and rubella (MMR) vaccinations among Texas infants published today in JAMA Network Open. The study reveals a sharp increase in early MMR vaccinations among infants in Texas during the state’s 2025 measles outbreak, aligning...
Truveta research published in Radiology Advances introduces new AI model to estimate body composition from chest radiographs
Truveta is proud to announce the publication of its latest peer-reviewed research in Radiology Advances: “XComposition: Multimodal Deep Learning Model to Measure Body Composition Using Chest Radiographs and Clinical Data.” This groundbreaking study demonstrates the...
Regulatory-grade device evidence reimagined with new precision data from Truveta
Unique device identifier data linked with ADT and chargemaster data give medical device manufacturers unmatched visibility into device use, safety, and outcomes—accelerating regulatory submissions, discovering safety signals faster, and speeding innovation that shapes...
New study reveals shift in pediatric obesity treatment following AAP guidelines
BELLEVUE, Wash.—July 14, 2025—A groundbreaking study published today in Pediatrics Open Science shows a notable increase in the use of medication to treat pediatric obesity in the United States following the 2023 release of comprehensive guidelines by the American...
A new era in cancer research: Truveta offers the most complete, representative, and timely real-world data on all cancers
BELLEVUE, Wash. – May 8, 2025 – Today, Truveta announced a new era in cancer research with more than 7 million oncology patient journeys spanning more than 100 cancer types, delivering an unprecedented breadth of regulatory grade data to support researchers in...
A new Truveta study offers a hopeful sign: Syphilis incidence is down for the first time in decades
Published in the American Journal of Preventative Medicine, the new study shows that for the first time since its peak in 2022, syphilis incidence has declined, with larger decreases for men and young adults. BELLEVUE, WA — April 9, 2025 — A new study published in the...
New Truveta data and capabilities help researchers accelerate scientifically rigorous research
BELLEVUE, Wash. – March 26, 2025 – Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. The company also announced two new Truveta Studio...
